Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (1008)	6/28/1999 1:31:00 PM
From: scaram(o)uche	Respond to of 1073

Mike: CNBC mentions were about the RJR project...... no mention of SIBI, and I don't know of anyone other than DAK and Stuart who made the connection. Rick

To: Mike McFarland who wrote (1008)	6/28/1999 1:53:00 PM
From: Pseudo Biologist	Read Replies (1) \| Respond to of 1073

<RE. new RJ Reynolds unit> Mike, this is from the paragraph in the WSJ article that mentions other companies (in case the rain is too much -g-): ... the tobacco giant is entering a field already crowded with pharmaceuticals giants, further blurring the lines between the industries. One rival, Sibia Neurosciences Inc. of La Jolla, Calif., also has been working on nicotinic compound-based drugs to treat Alzheimer's and Parkinson's. Sibia recently inked a joint-research deal with Eli Lilly & Co. of Indianapolis, to develop drugs to treat these and other central-nervous system-disorders. ... PB